Pfiz­er do­nates first $5M in Russ­ian prof­its since the war start­ed to help Ukraini­ans

Pfiz­er is tak­ing a nov­el tac­tic in its ap­proach to the Russ­ian war against Ukraine as CEO Al­bert Bourla told staffers on Wednes­day that the com­pa­ny is putting its first $5 mil­lion in Russ­ian prof­its to­ward eight glob­al and lo­cal NGOs to sup­port hu­man­i­tar­i­an re­lief and re­sponse ef­forts in Ukraine.

“We will con­tin­ue to di­vert these prof­its to the Ukrain­ian peo­ple un­til peace is achieved. Un­til that time, we al­so stand firm in our de­ci­sion to cease all our clin­i­cal tri­als in Rus­sia and to halt all in­vest­ments in lo­cal man­u­fac­tur­ing,” Bourla wrote to col­leagues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER